Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals develops rare disease medicines with a foundation in hematology.
DEF 14AAug 21Latest SEC filing, period to Aug 21
Jul 30Latest story
July 2026
Sign inSign inAgios Pharmaceuticals develops rare disease medicines with a foundation in hematology.